Oncoplastic breast reduction surgery decreases rates of reoperation with no increased medical risk
Journal of Plastic, Reconstructive & Aesthetic Surgery · 2024
DOI: 10.1016/j.bjps.2023.10.134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Plastic, Reconstructive & Aesthetic Surgery, 2024. Verfasst von Lee H Kilmer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery , Maxillofacial & Oral Health, University of Virginia, 1215 Lee Street, Charlottesville, VA 22903, USA. Electronic addr…. Hauptthemen laut MEDLINE: Breast Neoplasms, Mammaplasty. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
The purpose of this study is to compare the oncologic, medical, and surgical outcomes of lumpectomy versus oncoplastic breast reduction surgery (OBRS) on a national scale. A national insurance-based database was queried for patients who had a lumpectomy with or without a same-day breast reduction by Current Procedural Terminology (CPT) codes. Patients were then matched by obesity, body mass index range, age, region, neoadjuvant chemotherapy, and outcomes were compared. There were 421,455 patients in the lumpectomy group and 15,909 patients in the OBRS group. After matching, 15,134 patients were identified in each group. Repeat lumpectomy or subsequent mastectomy was more common in the lumpectomy group (15.2% vs. 12.2%, p < 0.001). OBRS patients had higher rates of 90-day surgical complications including dehiscence, infection, fat necrosis, breast abscesses, and antibiotic prescription (p < 0.001). Meanwhile, any medical complication was less common in the OBRS group (3.7% vs. 4.5%, p = 0.001). Logistic regression revealed that OBRS was associated with decreased odds of repeat lumpectomy (OR = 0.71, 95% CI 0.66-0.77, p < 0.001) with no significant increased odds of subsequent mastectomy (OR = 1.01, 95% CI 0.91-1.11, p = 0.914). OBRS was found to be associated with decreased risk for reoperation in the form of lumpectomy without increased likelihood of subsequent mastectomy. Although OBRS was associated with increased wound complications, medical complications were found to occur less frequently. This study endorses increased consideration of OBRS when lumpectomy or OBRS is appropriate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Plastic Surgery , Maxillofacial & Oral Health, University of Virginia, 1215 Lee Street, Charlottesville, VA 22903, USA. Electronic address: lh3eh@uvahealth.org.
- School of Medicine, University of Virginia, 1215 Lee Street, Charlottesville, VA 22903, USA. Electronic address: aaw2js@virginia.edu.
- Department of Plastic Surgery , Maxillofacial & Oral Health, University of Virginia, 1215 Lee Street, Charlottesville, VA 22903, USA. Electronic address: bd6u@uvahealth.org.
- Department of Plastic Surgery , Maxillofacial & Oral Health, University of Virginia, 1215 Lee Street, Charlottesville, VA 22903, USA. Electronic address: jts3v@uvahealth.org.
- Department of Plastic Surgery , Maxillofacial & Oral Health, University of Virginia, 1215 Lee Street, Charlottesville, VA 22903, USA. Electronic address: cac5rb@uvahealth.org.
Zitieren
APA
Kilmer, L. H., Weidman, A. A., DeGeorge, B. R., Stranix, J. T., & Campbell, C. A. (2024). Oncoplastic breast reduction surgery decreases rates of reoperation with no increased medical risk. Journal of Plastic, Reconstructive & Aesthetic Surgery. https://doi.org/10.1016/j.bjps.2023.10.134
Vancouver
Kilmer LH, Weidman AA, DeGeorge BR, Stranix JT, Campbell CA. Oncoplastic breast reduction surgery decreases rates of reoperation with no increased medical risk. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2024. doi:10.1016/j.bjps.2023.10.134
BibTeX
@article{Kilmer2024,
author = {Kilmer, Lee H and Weidman, Allan A and DeGeorge, Brent R and Stranix, John T and Campbell, Chris A},
title = {Oncoplastic breast reduction surgery decreases rates of reoperation with no increased medical risk},
journal = {Journal of Plastic, Reconstructive & Aesthetic Surgery},
year = {2024},
doi = {10.1016/j.bjps.2023.10.134}
}
EUVIMED